Hengrui Pharma Announces 2025 Annual Shareholder Meeting Notification

核心變化恒瑞醫藥公布2025年度股東大會通知,為股東審閱公司業績和策略方向的例行治理活動。

Hengrui Pharmaceuticals (恒瑞医药)·中國Leadership & Governance
官方来源CNINFO (巨潮资讯网)Chinese原文cninfo.com.cn·
收錄於 Mar 26, 2026 03:28 (1d ago)
·
LinkedInX
Source ContextCNINFO (巨潮资讯网)

Hengrui Pharmaceuticals has issued a notice regarding its 2025 Annual Shareholder Meeting. This event is a key governance milestone, providing shareholders an opportunity to review company performance and strategic direction.

阅读完整原文cninfo.com.cn
来源层级:Official
分类:规范
收录时间:Mar 26, 2026 03:28
日期可信度:提取
基于企业官方来源。SigFact 从经验证的企业公告中提取并结构化信号。

Sign in to save notes on signals.

登录